Pharmacologic treatment of depression in women: PMS, pregnancy, and the postpartum period

Depression and Anxiety

Volumn 8, Issue SUPPL. 1, 1998, Pages 18-26

  Cohen, Lee S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ESTROGEN; FLUOXETINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PROGESTERONE; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; BREAST FEEDING; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSPHORIA; FEMALE; HUMAN; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PREMENSTRUAL SYNDROME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREMENSTRUAL SYNDROME;

EID: 0031727819     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:1+<18::AID-DA4>3.0.CO;2-P     Document Type: Article

References (105)

1. Ali S, Buelkesam J, Newport L (1986) early neurobehavioral and neurochemical alterations in rats prenatally exposed to imipramine. Neurotoxicol 7:361-380.
2. Altshuler LL, Burt VK., McMullen M, Hendrick V (1995) Breast-feeding and sertraline: a 24-hour analysis. J Clin Psychiatry 56:243-245.
3. Altshuler L, Hendrick V, Parry B (1995) Pharmacologic management of premenstrual disorder. Harv Rev Psychiatr 2:223-245.
4. American Academy of Pediatrics Committee on Drugs (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93(1)137-149.
5. Appleby L, Warner R, Whitton A, et al. (1997) A controlled study of fluoxetine and cognitive-behavioral counselling in the treatment of postnatal depression. BMJ 314(7085):932-936.
6. Auerbach JG, Hans SL, Marcus J, Maeir S (1992) Maternal psychotropic medication and neonatal behavior. Neurotoxicology and Teratology 14(6)399-406.
7. Bancroft J (1993) The premenstrual syndrome: a reappraisal of the concept and the evidence. Psychol Med S24:1-47.
8. Banister P, Dafoe C, Smith ESO, Miller J (1972) Possible teratogenicity of tricyclic antidepressants (letter). Lancet 1:838-839.
9. Beck AT, Rush AJ, Shaw BF (1979) Cognitive Therapy of Depression. New York: Guilford.
10. Brandenberg S, Tuynman-Qua H, Verheij R, Pepplinkhuizen S (1993) Treatment of premenstrual syndrome with fluoxetine: an open study. Int Clin Psychopharmacol 8:315-317.
11. Breyer-Pfaff U, Nill K, Entenmann A, Gaertner HJ (1995) Secretion of Amitriptyline and Metabolites into Breast Milk. Am J Psychiatry 152:(5)812-813.
12. Briggs G, Freeman R, Yaffe S (1994) Drugs in Pregnancy and Lactation. Baltimore, MD: William and Wilkins.
13. Buist A, Norman TR, Dennerstein L (1990) Breastfeeding and the use of psychotropic medication: a review. J Affective Dis 19:197-206.
14. Chambers C, Johnson K, Dick L, Felix RJ, Lyons Jones K (1996) Birth outcomes in pregnant women taking fluoxetine. The New England Journal of Medicine 335:(14)1010-1015.
15. Chiarello R, Cole J (1987) The use of psychostimulants in general psychiatry: A reconsideration. Arch Gen Psychiatr 44:285-295.
16. Cohen L (1996) Hetrogeneity of Postpartum Depressive Illness: Implications for Treatment. Presented at the Presented at Marce Society Conference; Sept 6, 1996; London, England.
17. Cohen L (1997) Treatment of psychiatric illness during pregnancy and the postpartum period. Annual meeting of the American Psychiatric Society, May 18, San Diego, CA.
18. Cohen L, Grush L, Bailey J, Rosenbaum JF (1997) Perinatal outcome following fluoxetine exposure: A Preliminary Report. Presented at the New Research Section, Annual Meeting of the American Psychiatric Society, May 20, 1997; San Diego, CA.
19. Cohen L, Robertson L, Goldstein J, et al. (1997) Impact of pregnancy on risk for relapse of MDD. Presented at the Paper Session, Annual meeting of the American Psychiatric Society; May 21, 1997; San Diego, CA.
20. Cohen LS, Altshuler LL (1997) Pharmacologic management of psychiatric illness during Pregnancy and the postpartum period. Psychiatric Clinics of North America. Annual of Drug Therapy. Saunders Publishing.
21. Cohen LS, Rosenbaum JR (1997a) Fluoxetine in pregnancy (letter). NEJM 336:(12)872.
22. Cohen LS, Rosenbaum JF (1997b) Psychotropic drug use during pregnancy: Weighing the risks. J Clin Psych (suppl) (in press).
23. Cohn JF, Tronick E (1989) Specificity of infants' response to mothers' affective behavior. J Am Acad Child Adolesc Psychiatry 28: (2)242-248.
24. Cowe L, Lloyd D, Dawling S (1982) Neonatal convulsions caused by withdrawal from maternal clomipramine. Brit Med J 284: 1837-8.
25. Coyle LR (1975) Changes in developing behavior following prenatal administration. Pharmacol Biochem Behav 3:799-807.
26. Crombie D, Pinsent RJ, Felming D (1972) Imipramine and pregnancy. Br Med J 1:745.
27. Cutrona CE (1983) Causal attributions and perimatal distress. J Abnorm Psychol 92:161-172.
28. Dalton K (1985a) Progesterone prophylaxis used successfully in postnatal depression. Practitioner 229:507-508.
29. Dalton K (1985b) Progesterone prophylaxis used successfully in postnatal depression. Practitioner 229:507-508.
30. Dean F, Kendell RE (1981) The symptomatology of puerperal illness. Br J Psychiatry 139:128.
31. DeCeballos M, Benedi A, DeFelipe C, DelRio J (1985) Prenatal exposure of rats to antidepressants enhances agonist affinity of brain dopamine receptors and dopamine-mediated behavior. Eur J Pharmacol 116:257-262.
32. DelRio J, Montero D, DeCeballos M (1988) Long lasting changes after perinatal exposure to antidepressants. Prog in Brain Rec 73:173-87.
33. Eggermont E (1973) Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet 2:680.
34. Elks ML (1993) Open trial of fluoxetine therapy for premenstrual syndrome. Southern Medical Journal 86: (5)503-507.
35. File SE, Tucker JC (1984) Prenatal treatment with clomipramine: Effects on the behavior of male and female adolescent rats. Psychopharmacology 82:221-224.
36. Goldstein DJ (1995) Effects of third trimester fluoxetine exposure on the newborn. Clinical Psychopharmacology 15:417-420.
37. Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI (1989) Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum period. J Consulting and Clinical Psychol 57:269-274.
38. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347:(9006)930-933.
39. Hammarback S, Backstrom T, Holt J, et al. (1985) Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestogen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64:393-397.
40. Heinonen O, Sloan D, Shapiro S (1977) Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Services Group.
41. Henderson AF, Gregoire AJ, Kumar RC (1991) Treatment of severe postnatal depression with oestradiol skinpatches. Lancet 338:816-817.
42. Hirschfeld R, Keller M, Panico S, Aarons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M (1997) The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 227:333-40.
43. Hirshfeld DR, Rosenbaum JF, Biederman J, Bolduc EA, Faraone SV, Snidman N, Reznick JS, Kagan J (1992) Stable behavioral inhibition and its association with anxiety disorder. J Am. Acad. Child Adolesc. Psychiatry 31: (1)103-111.
44. Inman W, Kobotu K, Pearce G, et al. (1993) Prescription event monitoring of paroxetine. PEM Reports PXL 1206:1-44.
45. Jacobs D (1972) Imipramine (tofranil) (letter). SA Med Journal 46:1023.
46. Jason K, Cooper T, Friedman E (1981) Prenatal exposure to imipramine alters early behavioral development and Bear adrenergic receptors in rats. J Pharmacol Exp Ter 217:461-6.
47. Keller MB, Lovori PW, Lewis C, Klerman GL (1983) Predictors of relapse in major depressive disorder. JAMA 250:3299-3309.
48. Kendell RE, Chalmers JC, Platz C (1986) Epidemiology of puerperal psychoses. Br J Psychiatry 150.662-673.
49. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993) Sex and depression in the national comorbidity survey I: Lifetime prevalence, chronicity and recurrence. J Affect Dis 29:85-96.
50. Klerman GL, Weissman MM, Rounsaviile BJ, et al. (1984) Interpersonal psychotherapy of depression. Ed. New York City: Basic Books, Inc., Publishers.
51. Lederman R (1995) Relationship of anxiety, stress, and psychosocial development to reproductive health. Beh Med 21:101.
52. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W (1993) Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adol Psychiatry 32: (6)1253-1255.
53. Matheson I, Panele H, Alertson AR (1985) Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet ii:1124.
54. McBride WG (1972) Limb deformities associated with ininodibenzyl hydrochloride (letter). Med J Aust 1:492.
55. McElhatton P, Garbis H, Elefant E, Vial T, Bellemin B, Mastroiacovo P, Arnon J, Rodriguez-Pinella E, Schaéfer L, Pexieder T, Merlob P, Del Verme S (1996) The outcome of pregnancy in 689 women exposed to theraputic doses of antidepressants. A collaborative study of the European Network to Teratology Information Services (ENTIS). Reproductive Toxicology 1C (4)285-294.
56. McEwan B (1994) Steroid hormone actions on the brain: When is the genome involved? Hormones and Behavior 28:396-405.
57. Menkes DB, Taghavi E, Mason PA, Spears GFS, Howard RC (1992) Fluoxetine treatment of severe premenstrual syndrome. BMJ 305:346-347.
58. Menkes DB, Taghavi E, Mason PA, Howard RC (1993) Fluoxetine's spectrum of action in premenstrual syndrome. Int Clin Ps 8: (2)95-102.
59. Misri S, Sivertz K (1991) Tricyclic drugs in pregnancy and lactation: A preliminary report. IntJ Psychiatr in Med 21: (2)157-71.
60. Morrow AW (1972) Imipramine and congenital abnormalities. NZ Med Journal 75:1972.
61. Mueller T, Leon A, Keller M, et al. (1997) Ten-Year cumulative probability of recurrence after recovery from an index episode of MDD. Presented at the New Research Section, Annual Meeting of the American Psychiatric Association; May 20, 1997; San Diego, CA.
62. Nulman I, Koren G (1996) The safety of fluoxetine during pregnancy and lactation. Teratology 53:304-308.
63. Nulman I, Rovet J, Stewart D, Wolpin J, Allan Gardner H, Theis JG, Kulin N, Koren G (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336:258-62.
64. O'Hara MW (1986) Social support, life events, and depression during pregnancy and the pueperium. Arch Gen Psychiatry 43:569-573.
65. O'Hara MW (1991) Postpartum mental disorders. In: Sciarra JJ (eds): Gynecology and Obstetrics. Philadelphia- Harper & Row.
66. O'Hara MW (1995) Postpartum depression: Causes and consequences. New York: Springer-Verlag.
67. O'Hara MW, Neunaber DJ, Zekoski EM (1984) A prospective study of postpartum depression: Prevalence, course, and predictive factors. J Abnorm Psych 93:158.
68. O'Hara MW, Schlechte JA, Lewis DA, et al. (1991) Controlled prospective study of postpartum mood disorders: Psychological, environmental, and hormonal factors. J Abnorm Psychol 100.
69. O'Hara MW, Schlechte JA, Lewis DA, Wright EJ (1991) Prospective study of postpartum blues: Biologic and psychosocial factors. Arch Gen Psychiatry 48:801-806.
70. Orr S, Miller C (1995) Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiologic Reviews 17: (1)165-71.
71. Pastuszak AL, Milich V, Can S (1993) Prospective assessment of pregnancy outcome following first trimester exposure to benzodiazepines. Presented at the Sixth International Conference on Teratogen Information Services.
72. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Horn M, Koren G (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269: (17)2246-2248.
73. Pearlstein T, Stone A (1994) Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 55:332-5.
74. Pearlstein T, Stone A, Lund S, Scheft H, Zlotnich C, Borwn WA (1997) Comparison of fluoxetine, buproprion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psycho-pharmacol 17:261-266.
75. Perkin MR, Bland JM, Peacock JL, Anderson HR (1993) The effect of anxiety and depression during pregnancy on obstetric complications. Br J Obst G 100: (7)629-634.
76. Post R, Ballenger J (1984) Neurobiological Correlates of Depression and Anxiety. In: Post R, Balenger J (eds): Neurobiology of Mood Disorders. Williams and Wilkins.
77. Rachelefsky G, Flynt J, Ebbin A (1971) Possible teratogenicity of tricyclic antidepressants. Lancet 1:838.
78. Rickels K, Freeman E, Sondheimer S, Albert J (1990) Fluoxetine in the treatment of premenstrual syndrome. Curr Ther Res 48: 161-5.
79. Riordan J (1993) Drugs and Breastfeeding. In: Riordan J, Auerbach KG (eds): Breastfeeding and Human Lactation. Boston: Jones and Bartlett pp 135-152.
80. Sapolski R, Meaney M (1986) Maturation of the adrenotcortical stress response: Neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 11:65-76.
81. Scanlon F (1969) Use of antidepressant drugs first trimester (letter). Med J August 1077.
82. Schimmel M, Katz E, Shaag Y, Pastuszak A, Koren G (1991) Toxic neonatal effects following maternal clomipramine therapy. Clin Toxicol 29:479-84.
83. Schmidt P (1991) Lack of effect of induced menses in women with premenstrual syndrome (editorial). N Engl J Med 324.
84. Schmidt P, Nieman L, Grover G (1991) Lack of effects of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324:1174-1179.
85. Shearer WT, Schreiner RL, Marshall RE (1972) Urinary retention in a neonate secondary to maternal ingestion of nortripryline. J Pediatr 81:570-572.
86. Sim M (1972) Imipramine and pregnancy. Br Med J 2:45.
87. Spencer M (1993) Fluoxetine hydrochloride (Prozac) toxicity in the neonate. Pediatrics 92:721-2.
88. Steer RA, Scholl TO, Hediger ML, Fischer RL (1992) Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 45: (10)1093-1099.
89. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D (1992) Fluoxetine treatment of severe premenstrual dysphoria. New Eng J Med 332: (23)1529-1534.
90. Stone A, Pearlstein T, Brown W (1991) Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 52:290-293.
91. Stoukides JA, Stoukides CA (1991) Extrapyramidal symptoms upon discontinuation of fluoxetine (letter). AmJ Psychiatr 148:1263.
92. Stowe ZN, Casarella J, Landrey J, et al. (1995) Setraline in the treatment of women with postpartum major depression. Depression 3:49-55.
93. Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A, Nemeroff CB (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psych 154:1255-1260.
94. Stuart S, O'Hara MW (1995) Treatment of postpartum depression with interpersonal psychotherapy (letter; comment). Arch Gen Psychiatry 52: (1)75-76.
95. Sunblad C, Modigh K, Andersch B, Eriksson E (1992) Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta Psychiatr Scand 85:39-47.
96. Tamer A, McKey R, Arias D, Worley L, Fogel BJ (1969) Phenothiazine-induced extrapyramidal dysfunction in the neonate. J Pediatr 75: (3)479-480.
97. Tohen M, Waternaux CM, Tsuang MT (1990) Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatr 47: (12)1106-11.
98. Webster PAC (1973) Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet 2:318-319.
99. Weissman MM, Merikangas KR (1986) The epidemiology of anxiety and panic disorders: An update. J Clin Psychiatry 47: (6), suppl.) 11-17.
100. Wisner KL, Perel JM (1991) Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 148:1234-1236.
101. Wisner K, Perel J, Findling R (1996) Antidepressant treatment during breastfeeding. Am J Psychiatry (153)1132-1137.
102. Wood SH, Mortola JF, Chang Y, Moossazaden F, Yen SSC (1992) Treatment of premenstrual syndrome with fluoxetine: A double-blind, placebo-controlled, crossover study. Obstet Gynecol 80: (3)339-344.
103. Yonkers K, Halbreich U, Freeman E, Brown C, Endicott S, Frank E, Parry B, Perlstein T, Severino S, Stout S, Stone A, Harrison W (1997) Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 278: (12)983-988.
104. Zajicek E (1981) Psychiatric problems during pregnancy. In: Wolkind S, Zajicek E (eds): Pregnancy: A Psychological and Social Study. London: Academic, pp 57-73.
105. Zuckerman B, Bauchner H, Parker S, Cabrai H (1990) Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 11: (4)190-194.